My Fund Comparison
H&Q Life Sciences Investors Pays Stock Distribution
Hambrecht & Quist Capital Management, LLC
Boston, February 8, 2008 -- On February 8, 2008 H&Q Life Sciences Investors declared a stock distribution of $0.31 per share. The record date for the stock distribution is February 22, 2008 and the payable date is March 31, 2008. The Fund will trade ex-distribution on February 20, 2008.
This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, March 19, 2008. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts at the transfer agent who will have whole and fractional shares added to their account.
Shareholders may request to be paid in cash instead of shares by responding to the bank, brokerage or nominee who holds the shares if the shares are in "street name" or by filling out an election card received from Computershare Investor Services shortly after the record date if the shares are in registered form. The bank, brokerage or nominee who holds the shares must advise the Depository Trust Company ("DTC") as to their full and fractional share requirements by March 18, 2008. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to March 18, 2008.
Since the Fund's inception on May 8, 1992, the Fund's net asset value per share has ranged from a high of $44.80 to a low of $9.98 (unadjusted for capital gains of $20.32). The market price per share has ranged from a high of $41.06 to a low of $8.13. The stock price to net asset value premium has been as high as 13.7% and the discount as wide as 29.9%. On February 7, 2008, the closing stock price was $13.07 and the net asset value per share was $14.54, representing a discount of 10.11%.
H&Q Life Sciences Investors (NYSE: HQL) is a closed-end fund that invests in public and private companies in the life sciences industries. Hambrecht & Quist Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
View more information on Hambrecht & Quist Capital Management or other Closed-End Funds
CEF Investment Outlook: Webinar
Closed-end Funds 101
Pros and Cons of a Managed Distributions Policy
Understanding the Advantages of Closed-end Funds
Other Education Resources
National Association of
Publicly Traded Partnerships
Powered by a SySys®
data & content management system.
©Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.